LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
0.31623
37.71 27.76 41 2877 0.0142 0.0600
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
37.71 27.76 788 2877 0.2738 0.6482
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
37.71 27.76 48 2877 0.0167 0.0852
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
37.71 27.76 936 2877 0.3253 0.6912
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
39.41 27.76 45 3105 0.0145 0.0736
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
39.41 27.76 860 3105 0.2769 0.6561
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
39.41 27.76 59 3105 0.0190 0.1172
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
39.41 27.76 954 3105 0.3072 0.6816
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
41.11 27.76 48 3331 0.0144 0.0825
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
41.11 27.76 735 3331 0.2206 0.6070
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
41.11 27.76 56 3331 0.0168 0.1070
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
41.11 27.76 857 3331 0.2572 0.6431
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
42.81 27.76 54 3596 0.0150 0.0995
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
42.81 27.76 754 3596 0.2097 0.6008
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
42.81 27.76 69 3596 0.0192 0.1386
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
42.81 27.76 928 3596 0.2580 0.6489
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
44.52 27.76 60 3884 0.0154 0.1142
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
44.52 27.76 853 3884 0.2196 0.6169
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
44.52 27.76 66 3884 0.0170 0.1292
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
44.52 27.76 1012 3884 0.2605 0.6561
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
46.22 27.76 67 4125 0.0162 0.1299
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
46.22 27.76 853 4125 0.2068 0.6076
MN20160318_Q01
H15
MCF 10A-H2B-mCherry Neratinib
0.31623
46.22 27.76 61 4125 0.0148 0.1153
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
46.22 27.76 1040 4125 0.2521 0.6523
MN20160318_Q01
I20
MCF 10A-H2B-mCherry Neratinib
0.31623
47.93 27.76 58 4421 0.0131 0.1060
MN20160318_Q01
H15